Advertisement
Ascendis Pharma Says FDA Accepts Resubmitted NDA For TransCon PTH In Adults With Hypoparathyroidism
(RTTNews) - Ascendis Pharma A/S (ASND) announced Monday that the U.S. Food & Drug Administration (FDA) has accepted for review the Company's resubmitted New Drug Application (NDA) for TransCon PTH (palopegteriparatide) for the treatment of adult patients with hypoparathyroidism.
The agency considered the resubmission a complete, class 2 response and set a Prescription Drug User Fee Act (PDUFA) goal date of May 14, 2024.
In the United States, TransCon PTH (palopegteriparatide) is an investigational prodrug of parathyroid hormone (PTH [1-34]) for adult patients with hypoparathyroidism.
read more
Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism
Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom's Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism
RTTNews
|
461 days ago
Swiss Market Closes On Firm Note
The Switzerland market shrugged off a somewhat shaky start and climbed higher on Tuesday with investors mostly reacting to corporate earnings updates, and looking ahead to monetary policy announcement from the Federal Reserve and closely following trade talks.
RTTNews
|
2h 57min ago
European Stocks Close Higher As Investors React To Earnings
European stocks closed on a firm note on Tuesday as investors reacted to a slew of earnings announcements from the region, and looked ahead to monetary policy announcements from some leading central banks, including the U.S. Federal Reserve.
RTTNews
|
3h 19min ago
TSX Pares Some Gains After Hitting New High; Celestica Rises On Strong Results
The Canadian market is up in positive territory a little past noon on Tuesday, supported by gains in technology, real estate, healthcare and consumer staples sectors.
In addition to following the developments on the trade front, investors are also looking ahead to the monetary policy announcements from the Bank of Canada and the Federal Reserve.
RTTNews
|
4h 18min ago
U.S. Job Openings Decrease Slightly Less Than Expected In June
The Labor Department released a report on Tuesday showing job openings in the U.S. decreased by slightly less than expected in the month of June.
RTTNews
|
6h 29min ago
U.S. Consumer Confidence Modestly Improves In July
Consumer confidence in the U.S. saw a modest improvement in the month of July, according to a report released by the Conference Board on Tuesday. The Conference Board said its consumer confidence index rose to 97.2 in July after falling to a revised 95.2 in June.
RTTNews
|
6h 36min ago
Eurozone Consumers Lower 1-Year Inflation Expectation: ECB Survey
Euro area households' inflation expectations for the short-term eased in June while they medium to longer term forecasts for price growth were unchanged, survey data from the European Central Bank showed on Tuesday.
RTTNews
|
7h 39min ago
Bay Street Seen Opening Slightly Higher
Canadian shares may open higher Tuesday morning, riding on firm oil and metal prices. Investors, awaiting trade talks between Canadian and U.S. officials, also look ahead to Bank of Canada's interest rate decision, due on Wednesday.
RTTNews
|
7h 57min ago
